LENZ Therapeutics annual gross margin
2025
LENZ Therapeutics Gross Margin Growth & History (LENZ)
LENZ Therapeutics's gross margin was 97.81% for fiscal 2025.
View full LENZ Therapeutics company overviewLENZ Therapeutics annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 97.81% | — |
LENZ Therapeutics quarterly gross margin
Q2.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 94.90% | −5.10 pp |
| Q1 2026 | 2026-03-31 | 43.40% | — |
| Q2 2025 | 2025-06-30 | 100.00% | — |
LENZ Therapeutics gross margin trends
The latest reported quarter, Q2 2026, shows 94.90%.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review LENZ Therapeutics source filings ↗